Murphy, David L.
Lebin, Jacob A.
Severtson, Stevan G.
Olsen, Heather A.
Dasgupta, Nabarun
Dart, Richard C.
Article History
First Online: 26 March 2018
Compliance with Ethical Standards
:
: The Poison Center Program study protocol received its most recent review and approval from the Colorado Multiple Institutional Review Board (COMIRB) on 21 December 2016. In addition, the study protocol was reviewed and approved by the IRB of each participating poison center.
: There were no sources of financial assistance that were used to conduct this study or used to assist with the preparation of the manuscript.
: David Murphy, Jacob Lebin, Stevan Severtson, Nabarun Dasgupta, Heather Olsen, and Richard Dart have no conflicts of interest that are directly relevant to the content of this study. It should be noted that most manufacturers of prescription opioid analgesics or stimulants have subscription contracts to receive data from RADARS System. RADARS System is the property of Denver Health and Hospital Authority, a political subdivision of the State of Colorado (public hospital for Denver, Colorado). The subscribers receive data, they do not participate in developing the System, participate in data collection or the analysis of the data, nor do they have access to the raw data. No employee of Denver Health has a financial relationship nor receives any payment from any pharmaceutical company.